Thalidomide as "salvage" therapy for patients with delayed hypersensitivity response to infliximab: a case series.
Thalidomide as "salvage" therapy for patients with delayed hypersensitivity response to infliximab: a case series. J Clin Gastroenterol. 2002 Aug; 35(2):149-50.